Categorized | Melanoma News

Melanoma Journal Articles for May 2018

Cancer Discovery

Dual MAPK/CDK Targeting in Melanoma: New Approaches, New Challenges

Ryan J. Sullivan

DOI: 10.1158/2159-8290.CD-18-0224 Published May 2018

_________________________________________________________________

BMC

Vemurafenib in Chinese patients with BRAFV600mutation–positive unresectable or metastatic melanoma: an open-label, multicenter phase I study

Lu Si, Xiaoshi Zhang, Zhen Xu, Qiudi Jiang, Lilian Bu, Xuan Wang, Lili Mao, Weijiang Zhang, Nicole Richie and Jun Guo

BMC Cancer201818:520

https://doi.org/10.1186/s12885-018-4336-3

Received: 14 November 2016

Accepted: 12 March 2018

Published: 3 May 2018

______________________________________________________

Dove Press

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry

Authors Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LAVeierød MB

Received 8 September 2017

Accepted for publication 27 January 2018

Published 9 May 2018 Volume 2018:10 Pages 537—548

DOI https://doi.org/10.2147/CLEP.S151246

________________________________________________________

 

Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas

Alexandra Giantini Larsen, BS Benjamin L Grannan, MD Christine K Lee, MD, PhDMatthew J Koch, MD Erik A Williams, MD Matthew P Frosch, MD, PhDDaniel P Cahill, MD, PhD

Journal of Neuropathology & Experimental Neurology, nly029, https://doi.org/10.1093/jnen/nly029

_____________________________________________________________________________

 

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Devin Dressman, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Felicia L. Lenzo, Angela Omilian, Wiam Bshara, Matthew Zibelman, Pooja Ghatalia, Konstantin Dragnev, Keisuke Shirai, Katherine G. Madden, Laura J. Tafe, Neel Shah, Deepa Kasuganti, Luis de la Cruz-Merino, Isabel Araujo, Yvonne Saenger, Margaret Bogardus, Miguel Villalona-Calero, Zuanel Diaz, Roger Day, Marcia Eisenberg, Steven M. Anderson, Igor Puzanov, Lorenzo Galluzzi, Mark Gardner and Marc S. Ernstoff

Journal for ImmunoTherapy of Cancer20186:32

https://doi.org/10.1186/s40425-018-0344-8

 

Received: 13 February 2018

Accepted: 20 April 2018

Published: 9 May 2018

___________________________________________________________

 

Improving the Propranolol Treatment of Melanoma—Reply

Silvia Benemei, MD1Pierangelo Geppetti, MD1Vincenzo De Giorgi, MD2

JAMA Oncol. Published online May 10, 2018.

doi:10.1001/jamaoncol.2018.0619

______________________________________________________________

The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)

Michele Guida, Stefania Tommasi, Sabino Strippoli, Maria Iole Natalicchio, Simona De Summa, Rosamaria Pinto, Antonio Cramarossa, Anna Albano, Salvatore Pisconti, Michele Aieta, Ruggiero Ridolfi, Amalia Azzariti, Gabriella Guida, Vito Lorusso and Giusepe Colucci

BMC Cancer201818:552

https://doi.org/10.1186/s12885-018-4479-2

 

Received: 8 July 2016

Accepted: 2 May 2018

Published: 10 May 2018

_______________________________________________________________________

Dove Press

MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project

Authors Tagliabue EGandini S, Bellocco R, Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA, Ghiorzo P, Gruis NA, Landi MT, Menin CFargnoli MC, García-Borrón JC, Han J, Little JSera FRaimondi S

Received 26 October 2017

Accepted for publication 12 February 2018

Published 14 May 2018 Volume 2018:10 Pages 1143—1154

DOI https://doi.org/10.2147/CMAR.S155283

________________________________________________________________________

 

PRIMARY MALIGNANT MELANOMA OF THE SPINAL CORD

ARTHUR B. KING, M.D.JOHN W. CHAMBERS, M.D.JAMES GAREY, M.D.

AMA Arch NeurPsych. 1952;68(2):266-275. doi:10.1001/archneurpsyc.1952.02320200104012

_____________________________________________________________________

Cancer Research

 

NK cell editing mediates Epithelial to Mesenchymal Transition via phenotypic and proteomic changes in melanoma cell lines

Leticia Huergo Zapico, Monica Parodi, Claudia Cantoni, Chiara Lavarello, Juan L Fernández-Martínez, Andrea Petretto, Enrique J DeAndrés-Galiana, Mirna Balsamo, Alejandro López-Soto, Gabriella Pietra, Mattia Bugatti, Enrico Munari, Marcella Marconi, Maria Cristina Mingari, William Vermi, Lorenzo Moretta, Segundo Gonzalez and Massimo Vitale

DOI: 10.1158/0008-5472.CAN-17-1891

________________________________________________________________

Dove Press

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions

Authors Brewington BY, Shao YF, Davidorf FH, Cebulla CM

Received 9 August 2017

Accepted for publication 20 February 2018

Published 17 May 2018 Volume 2018:12 Pages 925—934

DOI https://doi.org/10.2147/OPTH.S129645

_________________________________________________________________

Clinical Cancer Research

Playing the melanoma endgame

Jessica L.F. Teh and Andrew E. Aplin

DOI: 10.1158/1078-0432.CCR-18-0989

Accepted May 10, 2018

_____________________________________________________________________

OncoImmunology

Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic target

Muhammad Zaeem Noman,Jerome Paggetti,Etienne Moussay,Guy Berchem &Bassam Janji

Article: e1452583 | Received 08 Mar 2018, Accepted 10 Mar 2018, Accepted author version posted online: 15 Mar 2018, Published online: 25 Apr 2018

https://doi.org/10.1080/2162402X.2018.1452583

____________________________________________________________________

Journal of Oncology Practice

Management of In-Transit Melanoma: We Need Some High-Quality Data

David E. Gyorki

DOI: 10.1200/JOP.18.00215

Journal of Oncology Practice 14, no. 5 (May 1 2018) 302-303.

______________________________________________

Advances in the systemic treatment of melanoma brain metastases 

I C Glitza Oliva G Schvartsman H Tawbi

Annals of Oncology, mdy185, https://doi.org/10.1093/annonc/mdy185

Published: 22 May 2018

________________________________________________________________

 

Cutaneous Eruption Secondary to Immunotherapy for Metastatic Melanoma Limited to Sites of Locoregional Melanoma Metastases A Possible Variant of Locus Minoris Resistentiae

Marie Donaldson, BA1Joshua L. Owen, MD, PhD1Jennifer N. Choi, MD1,2

JAMA Dermatol. Published online May 23, 2018. doi:10.1001/jamadermatol.2018.0654

_____________________________________________________

Biochimie

Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers

Dorota Hoja-?ukowicza, , Sabina SzwedaPiotr LaidlerbAnna Lity?skaa

 

https://doi.org/10.1016/j.biochi.2018.05.010

_____________________________________________________________

Journal of Molecular Biology

 

 

Genome-Wide RNAi Screen Identify Melanoma-Associated Antigen Mageb3 Involved in X Chromosome Inactivation

Wei Li1Ru Hong1Lan-Tian Lai1Qiman Dong3Peiling Ni3Rosi Chelliah1Mehnaz Huq1Siti Nadirah Binte Ismail1Udita Chandola1Zhiwei Ang1Bingqing Lin1Xin Chen2Lingyi Chen3, , ,

 

https://doi.org/10.1016/j.jmb.2018.05.031

___________________________________________________________

Molecular Pharmaceutics

In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma

Abner A. MurrayChao WangSteven Fiering, and Nicole F. Steinmetz

DOI: 10.1021/acs.molpharmaceut.8b00316

Publication Date (Web): May 25, 2018

__________________________________________________________

Cancer Letters

Pinocembrin induces ER stress mediated apoptosis and suppresses autophagy in melanoma cells

Yufei ZhengaKai WangbYuqi WuaYifan ChenaXi ChenaChenyue W. HucFuliang Hua, , 

 

https://doi.org/10.1016/j.canlet.2018.05.026

________________________________________________________________

Acta Physiologica

Cutaneous pH landscape as a facilitator of melanoma initiation and progression

Alexander Koch and Albrecht Schwab

First published: 26 May 2018

https://doi.org/10.1111/apha.13105

____________________________________________________________

Advanced Functional Materials

Targeted Nanoparticle?Mediated Gene Therapy Mimics Oncolytic Virus for Effective Melanoma Treatment

Li Luo, Yuping Yang, Ting Du, Tianyi Kang, Meimei Xiong, Hao Cheng, Yu Liu, Yujiao Wu, Yang Li, Yuwen Chen, Qianqian Zhang, Xuan Liu, Xiawei Wei, Peng Mi, Zhigang She, et al.

First published: 28 May 2018

https://doi.org/10.1002/adfm.201800173

__________________________________________________________________________

 

Annals of Oncology

Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists 

 

H A Haenssle C Fink R Schneiderbauer F Toberer T Buhl A Blum A Kalloo Hadj Hassen L Thomas A Enk  et.al.

Annals of Oncology, mdy166, https://doi.org/10.1093/annonc/mdy166

Published:28 May 2018

__________________________________________________________________

Science Translational Medicine

Ironing out dedifferentiation in melanoma

Tríona Ní Chonghaile

 

Science Translational Medicine  30 May 2018:
Vol. 10, Issue 443, eaau0461
DOI: 10.1126/scitranslmed.aau0461

______________________________________________________________________

Clinical Cancer Research

Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome

Marie-Andrée Forget, Cara Haymaker, Kenneth R. Hess, Yuzhong Jeff Meng, Caitlin Creasy, Tatiana V. Karpinets, Orenthial J. Fulbright, Jason Roszik, Scott E. Woodman, Young Uk Kim, Donastas Sakellariou-Thompson, Ankit Bhatta, Arely Wahl, Esteban Flores, Shawne T. Thorsen, Rene J. Tavera, Renjith Ramachandran, Audrey M. Gonzalez, Christopher Toth, Seth Wardell, Rahmatu Mansaray, Vruti Patel, Destiny Joy Carpio, Carol S. Vaughn, Chantell M. Farinas, Portia G. Velasquez, Wen-Jen Hwu, Sapna P. Patel, Michael A. Davies, Adi Diab, Isabella C. Glitza, Hussein Tawbi, Michael K.K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard Royal, J.N. Cormier, Jennifer A. Wargo, Laszlo G. Radvanyi, Carlos A. Torres Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria and Chantale Bernatchez

DOI: 10.1158/1078-0432.CCR-17-3649

_________________________________________________________________

 

 

Gilhooley E, McKenna D, “Determination of the impact of melanoma surgical timing on survival using the National Cancer Database”, Journal of the American Academy of Dermatology (2018), doi: 10.1016/j.jaad.2018.03.061.

________________________________________________________________________

Brain Metastases from Primary Tumors, Volume 3

Epidemiology, Biology, and Therapy of Melanoma and Other Cancers

2016, Pages 185–196

 

Chapter 13 – Patients with Brain Metastases from Melanoma: Treatment with Surgery and Radiotherapy

 

Michael N. KhourySymeon MissiosNam D. TranPeter A. Forsyth

 

https://doi.org/10.1016/B978-0-12-803508-5.00013-5

__________________________________________________________

Dove Press

Melanoma treatment in review

Authors Domingues B, Lopes JMSoares P, Pópulo H

Received 30 January 2018

Accepted for publication 16 March 2018

Published 7 June 2018 Volume 2018:7 Pages 35—49

DOI https://doi.org/10.2147/ITT.S134842

___________________________________________________